RPS6KC1 and benign prostatic hyperplasia: Our analysis, utilizing a pooled cohort from The Cancer Genome Atlas (TCGA), revealed that RPS6KC1 is significantly overexpressed in PCa patients compared to those with benign prostatic hyperplasia (BPH).